A detailed history of Soleus Capital Management, L.P. transactions in Establishment Labs Holdings Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 59,400 shares of ESTA stock, worth $2.73 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
59,400
Previous 15,000 296.0%
Holding current value
$2.73 Million
Previous $681,000 276.95%
% of portfolio
0.22%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$34.4 - $48.99 $1.53 Million - $2.18 Million
44,400 Added 296.0%
59,400 $2.57 Million
Q2 2024

Aug 14, 2024

BUY
$41.46 - $59.86 $621,900 - $897,900
15,000 New
15,000 $681,000
Q4 2022

Feb 14, 2023

SELL
$51.0 - $72.94 $1.16 Million - $1.66 Million
-22,700 Reduced 36.25%
39,920 $2.62 Million
Q3 2022

Nov 14, 2022

SELL
$50.45 - $67.84 $796,101 - $1.07 Million
-15,780 Reduced 20.13%
62,620 $3.42 Million
Q2 2022

Aug 15, 2022

BUY
$50.15 - $84.52 $3.93 Million - $6.63 Million
78,400 New
78,400 $4.26 Million
Q3 2021

Nov 15, 2021

SELL
$65.48 - $88.21 $1.74 Million - $2.34 Million
-26,568 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$65.47 - $87.34 $2.26 Million - $3.02 Million
-34,583 Reduced 56.55%
26,568 $2.32 Million
Q1 2021

May 17, 2021

SELL
$36.0 - $73.76 $207,720 - $425,595
-5,770 Reduced 8.62%
61,151 $3.82 Million
Q4 2020

Feb 16, 2021

BUY
$17.41 - $37.64 $1.17 Million - $2.52 Million
66,921 New
66,921 $2.52 Million
Q2 2020

Aug 14, 2020

SELL
$11.73 - $20.76 $741,969 - $1.31 Million
-63,254 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$7.56 - $28.98 $229,113 - $878,267
-30,306 Reduced 32.39%
63,254 $914,000
Q4 2019

Feb 14, 2020

BUY
$17.32 - $27.66 $1.62 Million - $2.59 Million
93,560 New
93,560 $2.59 Million

Others Institutions Holding ESTA

About ESTABLISHMENT LABS HOLDINGS INC.


  • Ticker ESTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,268,500
  • Market Cap $1.11B
  • Description
  • Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone...
More about ESTA
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.